InvestorsHub Logo

H2R

Followers 42
Posts 2156
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Tuesday, 05/23/2017 3:22:57 PM

Tuesday, May 23, 2017 3:22:57 PM

Post# of 1569
New Corporate Pres at http://ir.cytokinetics.com/phoenix.zhtml?c=142156&p=irol-irhome

It's funny how this board has so few active members. It's a game changer if the trials are positive and they do have a strong balance sheet (Cash, cash equivalents and investments $257.2*, slice 56), investors, etc.

Fully Diluted Shares Outstanding – Common Stock Only 57,972 (Slide 58)

They re-iterated "Data from VITALITY-ALSExpected in Q4" (Slide 29); To me, that's the big one. And not that far out either...

and "Expect Data from Phase 2 Trial in Japan in Q3" (Slide 54)


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News